126 related articles for article (PubMed ID: 23397675)
1. Nonhistaminergic idiopathic angioedema: clinical response to icatibant.
Colás C; Montoiro R; Fraj J; Garcés M; Cubero JL; Caballero T
J Investig Allergol Clin Immunol; 2012; 22(7):520-1. PubMed ID: 23397675
[No Abstract] [Full Text] [Related]
2. Treatment of idiopathic nonhistaminergic angioedema with bradykinin B2 receptor antagonist icatibant.
Del Corso I; Puxeddu I; Sardano E; Geraci S; Breggia M; Rocchi V; Migliorini P
Ann Allergy Asthma Immunol; 2012 Jun; 108(6):460-1. PubMed ID: 22626601
[No Abstract] [Full Text] [Related]
3. Successful treatment of a facial attack of angioedema with icatibant in a patient with idiopathic angioedema.
Montinaro V; Loizzo G; Zito A; Castellano G; Gesualdo L
Am J Emerg Med; 2013 Aug; 31(8):1295.e5-6. PubMed ID: 23706583
[No Abstract] [Full Text] [Related]
4. Icatibant: a novel approach to the treatment of angioedema related to the use of angiotensin-converting enzyme inhibitors.
Gallitelli M; Alzetta M
Am J Emerg Med; 2012 Oct; 30(8):1664.e1-2. PubMed ID: 22100478
[TBL] [Abstract][Full Text] [Related]
5. [Icatibant is a new treatment option in life-threatening angioedema triggered by angiotensin-converting enzyme inhibitor].
Fast S; Henningsen E; Bygum A
Ugeskr Laeger; 2011 Oct; 173(41):2574-5. PubMed ID: 21985837
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic efficacy of icatibant in angioedema induced by angiotensin-converting enzyme inhibitors: a case series.
Bas M; Greve J; Stelter K; Bier H; Stark T; Hoffmann TK; Kojda G
Ann Emerg Med; 2010 Sep; 56(3):278-82. PubMed ID: 20447725
[TBL] [Abstract][Full Text] [Related]
7. Nonhistaminergic idiopathic angioedema may be a presentation of mast cell activation syndrome.
Afrin LB
J Investig Allergol Clin Immunol; 2013; 23(3):212. PubMed ID: 23967766
[No Abstract] [Full Text] [Related]
8. Icatibant , the bradykinin B2 receptor antagonist with target to the interconnected kinin systems.
Charignon D; Späth P; Martin L; Drouet C
Expert Opin Pharmacother; 2012 Oct; 13(15):2233-47. PubMed ID: 22970904
[TBL] [Abstract][Full Text] [Related]
9. Two cases of severe angio-oedema and rationale for their response to icatibant.
Akinduro OO; Patel V; Thomas T; Ahmad FU
BMJ Case Rep; 2015 Dec; 2015():. PubMed ID: 26678695
[No Abstract] [Full Text] [Related]
10. Idiopathic nonhistaminergic angioedema successfully treated with ecallantide, icatibant, and C1 esterase inhibitor replacement.
Stahl MC; Harris CK; Matto S; Bernstein JA
J Allergy Clin Immunol Pract; 2014; 2(6):818-9. PubMed ID: 25439384
[No Abstract] [Full Text] [Related]
11. Icatibant Compared to Steroids and Antihistamines for ACE-Inhibitor-Induced Angioedema.
Botnaru T; Robert A; Mottillo S
CJEM; 2017 Mar; 19(2):159-162. PubMed ID: 27189625
[TBL] [Abstract][Full Text] [Related]
12. Treatment with icatibant in the management of drug induced angioedema.
Bertazzoni G; Bresciani E; Cipollone L; Fante E; Galandrini R
Eur Rev Med Pharmacol Sci; 2015 Jan; 19(1):149-53. PubMed ID: 25635988
[TBL] [Abstract][Full Text] [Related]
13. [Treatment of alteplase-induced orolingual angioedema by means of icatibant].
Mas-Serrano M; Garcia-Pastor A; Tornero-Molina P; Vazquez-Alen P; Palacios-Mendoza MA; Gil-Nunez AC
Rev Neurol; 2019 Sep; 69(6):261-262. PubMed ID: 31497871
[TBL] [Abstract][Full Text] [Related]
14. Novel pharmacotherapy of acute hereditary angioedema with bradykinin B2-receptor antagonist icatibant.
Bas M; Bier H; Greve J; Kojda G; Hoffmann TK
Allergy; 2006 Dec; 61(12):1490-2. PubMed ID: 17073887
[No Abstract] [Full Text] [Related]
15. Treatment of acute edema attacks in hereditary angioedema with a bradykinin receptor-2 antagonist (Icatibant).
Bork K; Frank J; Grundt B; Schlattmann P; Nussberger J; Kreuz W
J Allergy Clin Immunol; 2007 Jun; 119(6):1497-503. PubMed ID: 17418383
[TBL] [Abstract][Full Text] [Related]
16. Icatibant Exposure During Pregnancy in a Patient With Hereditary Angioedema.
Zanichelli A; Mansi M; Periti G
J Investig Allergol Clin Immunol; 2015; 25(6):447-9. PubMed ID: 26817146
[No Abstract] [Full Text] [Related]
17. Successful long-term treatment with the bradykinin B2 receptor antagonist icatibant in a patient with hereditary angioedema.
Greve J; Hoffmann TK; Schuler P; Lang S; Chaker A; Bas M
Int J Dermatol; 2011 Oct; 50(10):1294-5. PubMed ID: 21950301
[TBL] [Abstract][Full Text] [Related]
18. Icatibant for the treatment of hereditary angioedema.
Cole SW; Lundquist LM
Ann Pharmacother; 2013 Jan; 47(1):49-55. PubMed ID: 23249729
[TBL] [Abstract][Full Text] [Related]
19. Successful treatment of an acute attack of acquired angioedema with the bradykinin-B2-receptor antagonist icatibant.
Weller K; Magerl M; Maurer M
J Eur Acad Dermatol Venereol; 2011 Jan; 25(1):119-20. PubMed ID: 20477917
[No Abstract] [Full Text] [Related]
20. Renin-angiotensin system inhibitors and angioedema: anesthetic implications.
Stojiljkovic L
Curr Opin Anaesthesiol; 2012 Jun; 25(3):356-62. PubMed ID: 22552531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
